最終更新日:2022/12/23
In this planned trial, doctors will remove cancer patients' T cells, “CRISPR” them, and then reinfuse them in the hope that they will recognize and attack the patients' cancers.
編集履歴(0)
In this planned trial, doctors will remove cancer patients' T cells, “CRISPR” them, and then reinfuse them in the hope that they will recognize and attack the patients' cancers.